• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Opexa Therapeutics, Inc. (OPXA)

    -NasdaqCM
    0.83 Down 0.04(5.12%) Mar 5, 3:58PM EST
    Add to Portfolio
    Prev Close:0.88
    Open:0.88
    Bid:N/A
    Ask:1.00 x 1000
    1y Target Est:4.00
    Beta:2.13
    Earnings Date:May 12 - May 18 (Est.)
    Day's Range:0.80 - 0.91
    52wk Range:0.67 - 2.20
    Volume:731,742
    Avg Vol (3m):188,583
    Market Cap:23.44M
    P/E (ttm):N/A
    EPS (ttm):-0.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OPXA

    Comparison

    Symbol% ChgMkt Cap
    OPXADown 5.12%23.44M
    SNYUp 0.04%127.26B
    TEVADown 0.09%48.14B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.51
    Quarterly EPS Est (Mar-15) :-0.15
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback